Applying the previously published 5-gene signature (CCL2, DMRT2, GADD45B, IL1RN, and IL8)26 to our cohort, we found that this model was not able to accurately predict NASH or fibrosis stage (Fig. 2). The gene discussed is CXCL8; the disease is metabolic dysfunction-associated steatohepatitis.